Acute LeukemiasASH Annual MeetingExclusive VideosMultimedia James Foran: Does Decitabine Maintenance Improve Survival in Older Patients With AML? Thursday, December 12, 2019 James M. Foran, MD, shares “compelling, but not definitive†results that appear to support the use of maintenance therapy with decitabine in older adults with acute myeloid leukemia.